Andrew Rankin, PhD
About Andrew Rankin, PhD
Andrew Rankin, PhD, serves as the Director of Precision Medicine in Clinical Development at Day One Biopharmaceuticals, focusing on advancing precision oncology for childhood cancer. He has a background in translational oncology and medical affairs, with previous roles at Foundation Medicine and a strong academic foundation in biology and cell and molecular biology.
Current Role at Day One Biopharmaceuticals
Andrew Rankin serves as the Director of Precision Medicine in Clinical Development at Day One Biopharmaceuticals. He has held this position since 2023, focusing on expanding the precision oncology paradigm specifically for childhood cancer. His role involves integrating molecular information into personalized medicine to enhance cancer care.
Previous Experience at Foundation Medicine
Prior to his current role, Andrew Rankin worked at Foundation Medicine in various capacities. He was a Scientist in Translational Oncology and Clinical Reporting from 2014 to 2015, followed by positions as Operations Manager from 2015 to 2017, Lead Operations Manager from 2017 to 2018, Senior Manager of Medical Affairs from 2018 to 2020, and Associate Director of Medical Affairs from 2020 to 2021. His tenure at Foundation Medicine spanned multiple roles that contributed to his expertise in oncology.
Educational Background
Andrew Rankin earned his Bachelor of Science degree in Biology with a minor in Chemistry from Eastern Nazarene College, completing his studies from 2000 to 2004. He then pursued a Ph.D. in Cell and Molecular Biology at Boston University School of Medicine, where he studied from 2004 to 2011. His educational background provides a strong foundation for his work in precision medicine.
Teaching Experience at Boston University
From 2008 to 2014, Andrew Rankin served as Head Instructor at Boston University Metropolitan College. In this role, he contributed to the education of students in the field of biology, leveraging his extensive knowledge and experience in molecular biology and oncology.
Leadership and Advocacy in Precision Medicine
Andrew Rankin emphasizes empowerment as a leadership strategy while addressing challenges in the field of precision medicine. He advocates for the integration of molecular information into personalized medicine, aiming to transform cancer care, particularly for pediatric patients.